Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Ovarian Neoplasms

  Free Subscription


Articles published in Int J Oncol

Retrieve available abstracts of 28 articles:
HTML format

Single Articles


    June 2008
  1. IZUTSU N , Maesawa C, Shibazaki M, Oikawa H, et al
    Epigenetic modification is involved in aberrant expression of class III beta-tubulin, TUBB3, in ovarian cancer cells.
    Int J Oncol. 2008;32:1227-35.
    PubMed     Related articles    Abstract available


  2. ZHU ZB , Lu B, Park M, Makhija SK, et al
    Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.
    Int J Oncol. 2008;32:1179-88.
    PubMed     Related articles    Abstract available


  3. OEI AL , Sweep FC, Thomas CM, Boerman OC, et al
    The use of monoclonal antibodies for the treatment of epithelial ovarian cancer (review).
    Int J Oncol. 2008;32:1145-57.
    PubMed     Related articles    Abstract available


    May 2008
  4. SUN G , Zhou J, Yin A, Ding Y, et al
    Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
    Int J Oncol. 2008;32:1065-71.
    PubMed     Related articles    Abstract available


    March 2008
  5. YOSHIDA Y , Kurokawa T, Nishikawa Y, Orisa M, et al
    Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin.
    Int J Oncol. 2008;32:673-81.
    PubMed     Related articles    Abstract available


  6. ISHIKAWA A , Kudo M, Nakazawa N, Onda M, et al
    Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones.
    Int J Oncol. 2008;32:565-74.
    PubMed     Related articles    Abstract available


    February 2008
  7. SHIN JS , Hong SW, Lee SL, Kim TH, et al
    Serum starvation induces G1 arrest through suppression of Skp2-CDK2 and CDK4 in SK-OV-3 cells.
    Int J Oncol. 2008;32:435-9.
    PubMed     Related articles    Abstract available


    October 2007
  8. MURUGESAN SR , Akiyama M, Einfeld DA, Wickham TJ, et al
    Experimental treatment of ovarian cancers by adenovirus vectors combining receptor targeting and selective expression of tumor necrosis factor.
    Int J Oncol. 2007;31:813-22.
    PubMed     Related articles    Abstract available


    September 2007
  9. CAI G , Wang J, Xin X, Ke Z, et al
    Phosphorylation of glycogen synthase kinase-3 beta at serine 9 confers cisplatin resistance in ovarian cancer cells.
    Int J Oncol. 2007;31:657-62.
    PubMed     Related articles    Abstract available


    August 2007
  10. ESTRELLA VC , Eder AM, Liu S, Pustilnik TB, et al
    Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Int J Oncol. 2007;31:441-9.
    PubMed     Related articles    Abstract available


  11. KAJIYAMA H , Shibata K, Terauchi M, Yamashita M, et al
    Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
    Int J Oncol. 2007;31:277-83.
    PubMed     Related articles    Abstract available


    July 2007
  12. EL-NAGGAR SM , Malik MT, Kakar SS
    Small interfering RNA against PTTG: A novel therapy for ovarian cancer.
    Int J Oncol. 2007;31:137-43.
    PubMed     Related articles    Abstract available


    May 2007
  13. YAO LQ , Feng YJ, Ding JX, Jing HM, et al
    Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia.
    Int J Oncol. 2007;30:1069-75.
    PubMed     Related articles    Abstract available


    April 2007
  14. YATOUJI S , El-Khoury V, Trentesaux C, Trussardi-Regnier A, et al
    Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Int J Oncol. 2007;30:1003-9.
    PubMed     Related articles    Abstract available


  15. ISHIYAMA S , Matsueda S, Jones LA, Efferson C, et al
    Novel natural immunogenic peptides from Numb1 and Notch1 proteins for CD8+ cells in ovarian ascites.
    Int J Oncol. 2007;30:889-98.
    PubMed     Related articles    Abstract available


    March 2007
  16. SKIRNISDOTTIR I , Sorbe B
    Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma.
    Int J Oncol. 2007;30:727-34.
    PubMed     Related articles    Abstract available


    January 2007
  17. BENOIT MH , Hudson TJ, Maire G, Squire JA, et al
    Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Int J Oncol. 2007;30:5-17.
    PubMed     Related articles    Abstract available


  18. ABBOUD ER , Coffelt SB, Figueroa YG, Zwezdaryk KJ, et al
    Integrin-linked kinase: a hypoxia-induced anti-apoptotic factor exploited by cancer cells.
    Int J Oncol. 2007;30:113-22.
    PubMed     Related articles    Abstract available


    November 2006
  19. EICKE N , Gunthert AR, Emons G, Grundker C, et al
    GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
    Int J Oncol. 2006;29:1223-9.
    PubMed     Related articles    Abstract available


  20. PAN ZZ , Bruening W, Godwin AK
    Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility.
    Int J Oncol. 2006;29:1201-5.
    PubMed     Related articles    Abstract available


    October 2006
  21. QIU L , Zhou C, Sun Y, Di W, et al
    Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.
    Int J Oncol. 2006;29:1003-11.
    PubMed     Related articles    Abstract available


  22. TAMMELA J , Uenaka A, Ono T, Noguchi Y, et al
    OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
    Int J Oncol. 2006;29:903-10.
    PubMed     Related articles    Abstract available


  23. BACHVAROV D , L'esperance S, Popa I, Bachvarova M, et al
    Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy.
    Int J Oncol. 2006;29:919-33.
    PubMed     Related articles    Abstract available


  24. BECKER K , Pancoska P, Concin N, Vanden Heuvel K, et al
    Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
    Int J Oncol. 2006;29:889-902.
    PubMed     Related articles    Abstract available


    September 2006
  25. ESCREVENTE C , Machado E, Brito C, Reis CA, et al
    Different expression levels of alpha3/4 fucosyltransferases and Lewis determinants in ovarian carcinoma tissues and cell lines.
    Int J Oncol. 2006;29:557-66.
    PubMed     Related articles    Abstract available


    August 2006
  26. TOUMA R , Kartarius S, Harlozinska A, Gotz C, et al
    Growth inhibition and apoptosis induction in ovarian cancer cells.
    Int J Oncol. 2006;29:481-8.
    PubMed     Related articles    Abstract available


    July 2006
  27. ZHOU C , Qiu L, Sun Y, Healey S, et al
    Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Int J Oncol. 2006;29:269-78.
    PubMed     Related articles    Abstract available


    February 2006
  28. ZHANG C , Marme A, Wenger T, Gutwein P, et al
    Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas.
    Int J Oncol. 2006;28:551-8.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: